|
|
Xueliang Du, Takeshi Matsumura, Diane Edelstein, Luciano Rossetti, Zsuzsanna Zsengellér, Csaba Szabó, Michael Brownlee
J Clin Invest. 2003;
112(7):1049
doi:10.1172/JCI18127
Abstract |
Full text
| PDF

I
n this report, we show that hyperglycemia-induced overproduction of superoxide by the mitochondrial electron transport chain activates the three major pathways of hyperglycemic damage found in aortic endothelial cells by inhibiting GAPDH activity. In bovine aortic endothelial cells, GAPDH antisense oligonucleotides activated each of the pathways of hyperglycemic vascular damage in cells cultured in 5 mM glucose to the same extent as that induced by culturing cells in 30 mM glucose. Hyperglycemia-induced GAPDH inhibition was found to be a consequence of poly(ADP-ribosyl)ation of GAPDH by poly(ADP-ribose) polymerase (PARP), which was activated by DNA strand breaks produced by mitochondrial superoxide overproduction. Both the hyperglycemia-induced decrease in activity of GAPDH and its poly(ADP-ribosyl)ation were prevented by overexpression of either uncoupling protein–1 (UCP-1) or manganese superoxide dismutase (MnSOD), which decrease hyperglycemia-induced superoxide. Overexpression of UCP-1 or MnSOD also prevented hyperglycemia-induced DNA strand breaks and activation of PARP. Hyperglycemia-induced activation of each of the pathways of vascular damage was abolished by blocking PARP activity with the competitive PARP inhibitors PJ34 or INO-1001. Elevated glucose increased poly(ADP-ribosyl)ation of GAPDH in WT aortae, but not in the aortae from PARP-1–deficient mice. Thus, inhibition of PARP blocks hyperglycemia-induced activation of multiple pathways of vascular damage.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(45)
| Title and authors |
Publication |
Year |
Protective Effects of Hydrogen Saline on Diabetic Retinopathy in a Streptozotocin-Induced Diabetic Rat Model
Xiang Xiao, Jiping Cai, Jiajun Xu, Ruobing Wang, Jianmei Cai, Yun Liu, Weigang Xu, Xuejun Sun, Runping Li
|
Journal of Ocular Pharmacology and Therapeutics
|
2011 |
Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function
K. Suzuki, G. Olah, K. Modis, C. Coletta, G. Kulp, D. Gero, P. Szoleczky, T. Chang, Z. Zhou, L. Wu, R. Wang, A. Papapetropoulos, C. Szabo
|
Proceedings of the National Academy of Sciences
|
2011 |
Effect of Diabetes on Alteration of Metabolism in Cardiac Myocytes: Therapeutic Implications
Sunil K. Kota, Siva K. Kota, Sruti Jammula, M. Pharm, Sandip Panda, Kirtikumar D. Modi
|
Diabetes Technology & Therapeutics
|
2011 |
Impaired Redox Signaling and Antioxidant Gene Expression in Endothelial Cells in Diabetes: A Role for Mitochondria and the Nuclear Factor-E2-Related Factor 2-Kelch-Like ECH-Associated Protein 1 Defense Pathway
Xinghua Cheng, Richard C.M. Siow, Giovanni E. Mann
|
Antioxidants & Redox Signaling
|
2011 |
Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy.
Masayoshi Takeuchi, Jun-Ichi Takino, Sho-Ichi Yamagishi
|
Journal of Ophthalmology
|
2010 |
Hyperglycemia and Glycation in Diabetic Complications
Anne Negre-Salvayre, Robert Salvayre, Nathalie Augé, Reinald Pamplona, Manuel Portero-Otín
|
Antioxidants & Redox Signaling
|
2009 |
Redox Control of Endothelial Function and Dysfunction: Molecular Mechanisms and Therapeutic Opportunities
Shane R. Thomas, Paul K. Witting, Grant R. Drummond
|
Antioxidants & Redox Signaling
|
2008 |
Transient Insulin Resistance in Normal Subjects: Acute Hyperglycemia Inhibits Endothelial-Dependent Vasodilatation in Normal Subjects
George Rammos, Vasileios Peppes, Nicolaos Zakopoulos
|
Metabolic Syndrome and Related Disorders
|
2008 |
Molecular mechanisms and clinical implications of reversible protein S-glutathionylation.
John J Mieyal, Molly M Gallogly, Suparna Qanungo, Elizabeth A Sabens, Melissa D Shelton
|
Antioxidants & Redox Signaling
|
2008 |
Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
Kateřina Kaňková
|
Proc. Nutr. Soc.
|
2008 |
|